Patients will receive additional education with standard of care treatment. Patients will be asked to complete the Demoralization Scale II and Female Sexual Function Index at baseline, 3-months following treatment, 6-months following treatment, and one-year following treatment. Patients will also be asked to complete an attendance diary documenting additional support services utilized. The Attendance Diary will be completed at 3-months following treatment, 6-months following treatment, and one-year following treatment.
Study-Specific Patient Handouts, Treating-Provider led counseling, Women’s Bladder Cancer Support Group, Women’s Bladder Cancer Educational Series, and referrals for additional support services Questionnaires: Female Sexual Function Index, Demoralization Scale-II, and Attendance Diaries
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.